Purple Biotech (PPBT) Short-term Investments (2017 - 2021)

Purple Biotech (PPBT) has disclosed Short-term Investments for 5 consecutive years, with $36.3 million as the latest value for Q4 2021.

  • On a quarterly basis, Short-term Investments fell 22.01% to $36.3 million in Q4 2021 year-over-year; TTM through Dec 2021 was $36.3 million, a 22.01% decrease, with the full-year FY2021 number at $36.3 million, down 22.01% from a year prior.
  • Short-term Investments was $36.3 million for Q4 2021 at Purple Biotech, down from $46.6 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $46.6 million in Q4 2020 to a low of $10000.0 in Q4 2019.
  • A 5-year average of $17.6 million and a median of $3.5 million in 2017 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: crashed 99.34% in 2019, then surged 465480.0% in 2020.
  • Purple Biotech's Short-term Investments stood at $3.5 million in 2017, then tumbled by 56.39% to $1.5 million in 2018, then plummeted by 99.34% to $10000.0 in 2019, then soared by 465480.0% to $46.6 million in 2020, then dropped by 22.01% to $36.3 million in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Short-term Investments are $36.3 million (Q4 2021), $46.6 million (Q4 2020), and $10000.0 (Q4 2019).